Ahmed Z , Anderson I M (2001) Treatment of bipolar affective disorder in clinical practice . J Psychopharmacol15: 55–57
2.
Allen D , Horvarth R , Nutt D (1993) Antidepressants and mania: to stop or not to stop?Hum Psychopharmacol8: 357–360
3.
Altshuler L , Suppes T , Black D , Nolen W A , Keck P E Jr , Frye M A , McElroy S , Kupka R , Grunze H , Walden J , Leverich G , Denicoff K , Luckenbaugh D , Post R (2003) Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow up . Am J Psychiatry160: 1252–1262
4.
American Psychiatric Association (2002) Practice guideline for the treatment of patients with bipolar disorder (revision) . Am J Psychiatry159: 1–50
5.
Brambilla P , Barale F , Soares J C (2003) Atypical antipsychotics and mood stabilization in bipolar disorder . Psychopharmacology166: 315–332
6.
Food and Drug Administration (2003) Letter posted 6 July 2003 to GlaxoSmithKline in respect of supplemental new drug applications for NDA 20-241/S-017 and NDA 20-764/S-011. http://www.fda.gov/cder/approval/index.htm (accessed 5 August 2003)
7.
Goodwin G M (2003) Evidence-based guidelines for treating bipolardisorder: recommendations from the British Association for Psycho-pharmacology . J Psychopharmacol17: 149–173
8.
Lloyd A J , Harrison C L , Ferrier I N , Young A H (2003) The pharmacological treatment of bipolar disorder: practice is improving but could still be better . J Psychopharmacol17: 230–233
9.
Shulman K I , Rochon P , Sykora K , Anderson G , Mamdani M , Bronskill S , Tran C T (2003) Changing prescription patterns for lithium and valproic acid in old age: shifting practice without evidence . Br Med J326: 960–961
10.
Tohen M , Ketter T A , Zarate C A , Suppes T , Frye M , Altshuler L , Zajecka J , Schuh L M , Risser R C , Brown E , Baker R W (2003) Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study . Am J Psychiatry160: 1263–1271
